• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素治疗膀胱过度活动症:尿潴留风险

Botulinum toxin treatment for overactive bladder: risk of urinary retention.

作者信息

Shaban Ahmed M, Drake Marcus J

机构信息

Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom.

出版信息

Curr Urol Rep. 2008 Nov;9(6):445-51. doi: 10.1007/s11934-008-0077-1.

DOI:10.1007/s11934-008-0077-1
PMID:18947508
Abstract

In recent years, botulinum-A neurotoxin has increasingly been used to manage lower urinary tract symptoms, including overactive bladder and detrusor overactivity (DO), either due to neurogenic or idiopathic etiology. Techniques, doses, and preparation vary. Although many studies have reported promising results regarding efficacy, potential adverse effects, particularly urinary retention, have been less comprehensively reported. We performed a critical review of published studies evaluating botulinum treatment for overactive bladder and its reported effects on voiding function. Acute urinary retention is recognized, though rare. Chronic urinary retention is inconsistently reported; it appears to be more common in neurogenic DO, but it can occur in idiopathic DO. Increased postvoid residuals have been reported by several studies, but the clinical significance that investigators attach to the observation varies. The detrimental effect of retention on quality of life can be considerable. Accordingly, patients should be fully counseled on the risks of urinary retention and trained in intermittent catheterization before the procedure. Postvoid residual assessment should be part of follow-up and patients should be warned of possible presentations.

摘要

近年来,A型肉毒杆菌神经毒素越来越多地被用于治疗下尿路症状,包括膀胱过度活动症和逼尿肌过度活动(DO),其病因可能是神经源性或特发性。技术、剂量和制剂各不相同。尽管许多研究报告了关于疗效的有前景的结果,但潜在的不良反应,尤其是尿潴留,却较少得到全面报道。我们对已发表的评估肉毒杆菌治疗膀胱过度活动症及其对排尿功能的报道影响的研究进行了严格审查。急性尿潴留虽被认识到,但很罕见。慢性尿潴留的报道并不一致;它似乎在神经源性DO中更常见,但也可能发生在特发性DO中。几项研究报告了排尿后残余尿量增加,但研究人员对这一观察结果的临床意义看法不一。尿潴留对生活质量的有害影响可能相当大。因此,在手术前,应向患者充分告知尿潴留的风险,并对其进行间歇性导尿训练。排尿后残余尿量评估应作为随访的一部分,并且应警告患者可能出现的情况。

相似文献

1
Botulinum toxin treatment for overactive bladder: risk of urinary retention.肉毒杆菌毒素治疗膀胱过度活动症:尿潴留风险
Curr Urol Rep. 2008 Nov;9(6):445-51. doi: 10.1007/s11934-008-0077-1.
2
Botulinum toxin treatment for bladder dysfunction.肉毒杆菌毒素治疗膀胱功能障碍。
Int J Urol. 2013 Oct;20(10):956-62. doi: 10.1111/iju.12188. Epub 2013 May 2.
3
Real-World Retention Rates After Intravesical OnabotulinumtoxinA for Idiopathic Overactive Bladder.膀胱内注射A型肉毒毒素治疗特发性膀胱过度活动症后的真实世界保留率
Female Pelvic Med Reconstr Surg. 2018 Nov/Dec;24(6):404-407. doi: 10.1097/SPV.0000000000000496.
4
Prolonged urinary retention after intravesical botulinum injection for treatment of idiopathic detrusor overactivity.膀胱内注射肉毒杆菌毒素治疗特发性逼尿肌过度活动后出现的长期尿潴留。
Can J Urol. 2011 Apr;18(2):5657-9.
5
Botulinum toxin A for the Treatment of Overactive Bladder.A型肉毒杆菌毒素治疗膀胱过度活动症
Toxins (Basel). 2016 Feb 29;8(3):59. doi: 10.3390/toxins8030059.
6
[Botulinum toxin type A in patients with overactive bladder].[A型肉毒杆菌毒素用于膀胱过度活动症患者]
Urologiia. 2010 May-Jun(3):36-40.
7
Predictors of Poor Response and Adverse Events Following Botulinum Toxin A for Refractory Idiopathic Overactive Bladder: A Systematic Review.肉毒杆菌毒素 A 治疗难治性特发性过度活动膀胱不良反应和疗效不佳的预测因素:系统评价。
Eur Urol Focus. 2021 Nov;7(6):1448-1467. doi: 10.1016/j.euf.2020.06.013. Epub 2020 Jun 29.
8
Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).第5章:神经源性逼尿肌过度活动(NDO)和膀胱过度活动症(OAB)的临床数据。
Neurourol Urodyn. 2014 Jul;33 Suppl 3:S26-31. doi: 10.1002/nau.22630.
9
Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity.重复膀胱内注射肉毒毒素 A 治疗逼尿肌过度活动的停药率和注射间隔。
Int J Urol. 2014 Feb;21(2):175-8. doi: 10.1111/iju.12205. Epub 2013 Jul 2.
10
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.注射用肉毒毒素 A 治疗膀胱过度活动症伴或不伴急迫性尿失禁患者的疗效:一项 3 期、随机、安慰剂对照试验的结果。
J Urol. 2017 Feb;197(2S):S216-S223. doi: 10.1016/j.juro.2016.10.109. Epub 2016 Dec 22.

引用本文的文献

1
Intravesical botulinum toxin: Practice patterns from a survey of Canadian urologists.膀胱内注射肉毒杆菌毒素:加拿大泌尿科医生调查的实践模式
Can Urol Assoc J. 2023 Jan;17(1):E15-E22. doi: 10.5489/cuaj.7886.
2
The use of botulinum neurotoxin type a in a patient with refractory urge incontinence to facilitate the intravesical treatment of bladder carcinoma.A型肉毒杆菌神经毒素在一名难治性急迫性尿失禁患者中的应用,以促进膀胱癌的膀胱内治疗。
Rev Urol. 2014;16(4):194-7.
3
Botulinum toxin A's expanding role in the management of pediatric lower urinary tract dysfunction.

本文引用的文献

1
Refractory idiopathic urge urinary incontinence and botulinum A injection.难治性特发性急迫性尿失禁与A型肉毒毒素注射
J Urol. 2008 Jul;180(1):217-22. doi: 10.1016/j.juro.2008.03.028. Epub 2008 May 21.
2
Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.A型肉毒杆菌神经毒素注射治疗逼尿肌过度活动症后对膀胱过度活动症状的早期影响。
Eur Urol. 2008 Jul;54(1):181-7. doi: 10.1016/j.eururo.2007.12.029. Epub 2007 Dec 26.
3
Muscarinic receptor antagonists for overactive bladder.
A型肉毒杆菌毒素在小儿下尿路功能障碍管理中的作用不断扩大。
Curr Urol Rep. 2014 Aug;15(8):426. doi: 10.1007/s11934-014-0426-1.
4
Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice.A型肉毒杆菌毒素治疗临床实践中神经源性逼尿肌过度活动的经验。
Ther Adv Urol. 2014 Feb;6(1):34-42. doi: 10.1177/1756287213510962.
5
Modulation of purinergic neuromuscular transmission by phorbol dibutyrate is independent of protein kinase C in murine urinary bladder.佛波酯对小鼠膀胱嘌呤能神经肌肉传递的调制作用不依赖于蛋白激酶 C。
J Pharmacol Exp Ther. 2012 Aug;342(2):312-7. doi: 10.1124/jpet.112.194704. Epub 2012 Apr 30.
6
The overactive bladder.膀胱过度活动症。
Ther Adv Urol. 2010 Aug;2(4):147-55. doi: 10.1177/1756287210373757.
7
Intravesical botulinum toxin for lower urinary tract dysfunction.膀胱内注射肉毒杆菌毒素治疗下尿路功能障碍。
F1000 Med Rep. 2010 Jan 27;2:6. doi: 10.3410/M2-6.
8
Management of overactive bladder.膀胱过度活动症的管理。
Nat Rev Urol. 2010 Oct;7(10):572-82. doi: 10.1038/nrurol.2010.147.
9
Etiology and management of urinary retention in women.女性尿潴留的病因与管理
Indian J Urol. 2010 Apr;26(2):230-5. doi: 10.4103/0970-1591.65396.
10
Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study.肉毒杆菌A毒素/二甲基亚砜膀胱灌注治疗难治性特发性逼尿肌过度活动症女性:一项1/2期研究
Mayo Clin Proc. 2009 Aug;84(8):702-6. doi: 10.4065/84.8.702.
用于治疗膀胱过度活动症的毒蕈碱受体拮抗剂。
BJU Int. 2007 Nov;100(5):987-1006. doi: 10.1111/j.1464-410X.2007.07205.x.
4
Botulinum injections for the treatment of bladder symptoms of multiple sclerosis.肉毒杆菌素注射治疗多发性硬化症的膀胱症状。
Ann Neurol. 2007 Nov;62(5):452-7. doi: 10.1002/ana.21209.
5
Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity.肉毒杆菌毒素A注射于逼尿肌、膀胱黏膜下层和膀胱底部治疗特发性逼尿肌过度活动的疗效比较
J Urol. 2007 Oct;178(4 Pt 1):1359-63. doi: 10.1016/j.juro.2007.05.136. Epub 2007 Aug 16.
6
Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.A型肉毒杆菌毒素治疗特发性逼尿肌过度活动症的疗效:一项单中心、随机、双盲、安慰剂对照试验的结果
J Urol. 2007 Jun;177(6):2231-6. doi: 10.1016/j.juro.2007.01.130.
7
Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?小剂量A型肉毒杆菌毒素膀胱黏膜下注射对难治性逼尿肌过度活动是否具有相似的治疗效果且不良事件更少?
Urology. 2006 Nov;68(5):993-7; discussion 997-8. doi: 10.1016/j.urology.2006.05.054.
8
Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.对100例抗胆碱能药物难治性特发性膀胱过度活动症患者进行肉毒杆菌A毒素膀胱逼尿肌注射治疗的经验。
J Urol. 2006 Jul;176(1):177-85. doi: 10.1016/S0022-5347(06)00590-8.
9
Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.肉毒杆菌毒素B对难治性逼尿肌过度活动的影响:一项随机、双盲、安慰剂对照的交叉试验。
J Urol. 2005 Nov;174(5):1873-7; discussion 1877. doi: 10.1097/01.ju.0000177477.83991.88.
10
Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.肉毒杆菌A毒素注射逼尿肌和括约肌治疗膀胱过度活动症:客观结果与患者满意度
Eur Urol. 2005 Dec;48(6):984-90; discussion 990. doi: 10.1016/j.eururo.2005.06.021. Epub 2005 Jul 18.